KIRN 670AM RADIOIRAN has been serving the Iranian-American/Persian population of Los Angeles for more than a decade. During the past year, John Paley, VP and General Manager of KIRN, organized a series of interactive informational broadcasts about breast and esophageal cancer. Teams of medical experts in these fields thoroughly reviewed signs, treatment, myths and realities about this implacable disease.
Listener phone and e-mail response to these programs was exceptional and led to the scheduling of additional programs on this subject.
On Saturday, December 4, 2010, KIRN 670AM, in conjunction with the Prostate Cancer Foundation, is placing prostate cancer on its agenda. This time the program is personal, as John Paley has recently been diagnosed with prostate cancer and has just started radiation treatments.
The three hour program (1pm-4pm) will air simultaneously on KIRN and its website www.670amkirn.com.
As always, listeners will be invited to ask questions of our assembled experts.
"Your emotions take over when your doctor says that dreaded word... cancer," says Paley. "You are suddenly faced with your morality. I immersed myself in cancer literature and the statistics are frightening. U.S. cancer deaths are estimated at nearly 600,000 for 2010... worldwide in the eight million range. By 2030 the estimate is 13 million deaths.
"One must understand the relationship between cancer and ageing. Cancer has become the price of modern life." As life expectancy has risen so has the incidence of cancer. The median age in the U.S. for breast cancer is sixty one; prostate cancer sixty-seven; colorectal seventy. An epidemiologist estimated that in the U.S. about half of all men and a third of all women will contract cancer in their lifetime.
"I realized that I had a rare opportunity as manager of a very unique radio station. KIRN and its website reaches hundreds of thousands Persians in Southern California and millions worldwide. It is singularly exclusive and believable within the Iranian-American and Persian population. The FCC mandate is to serve the 'public interest' and I will use the station to create a new awareness for prostate cancer and all of its deadly relatives. Fundraising will be an offshoot of the project, but education and awareness will be its primary function. KIRN will go further than the lip service of sixty second announcements."
FDA approval of Anktiva heralds a new era in the treatment of BCG-unresponsive non–muscle-invasive bladder cancer